SLC7A11 与 PD-L1 共表达增高与结外自然杀伤 T 细胞淋巴瘤患者不良预后相关
The increased co-expression of SLC7A11 and PD-L1 was associated with poor prognosis in extranodal natural killer T-cell lymphoma patients.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
FRONTIER PAPERS
前沿论文 3
近 5 年肿瘤细胞治疗领域的研究论文。默认按评分排序（权威性 + 新鲜度）。
抗代谢药物培门冬酶联合 PD-1 抗体信迪利单抗用于晚期自然杀伤 T 细胞淋巴瘤的一线治疗
Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma.
抗 CD47 抗体联合 CTLA4 阻断通过肿瘤血管正常化和免疫微环境重编程增强非小细胞肺癌的抗肿瘤免疫
The Combination of Anti-CD47 Antibody with CTLA4 Blockade Enhances Anti-Tumor Immunity in Non-Small Cell Lung Cancer via Normalization of Tumor Vascul
共 3 条